# AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-23 13:26 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Reuters | AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMiywFBVV95cUxOZEVtOEp1OEtIei1taHdqbUpRRzU2WG4zSjh4M2w3cFNnSzA1a3JUQVd3dWU3Q0MwcUtqWm1OeU4wSU9Ja0V4T3IyRDRwaDdIR05HV2ZHbVp5VlFrdElIU0RfRUdrRUNNNXdEeklDdkxWVVpLbklQZ2x4X3QwMUFCRlJ0MVB2QzBWOUFBenQ0bXFUd3otcVo1VWY1VzM2MXl6Qk56aEZTbWtSYXN5RkliQ040TFZBd1R4VlVGb0g1eGZwTW1PUWlWQlgyWQ?oc=5) |
| BioPharma Dive | AbbVie to acquire Apogee, staking nearly $11B on long-acting autoimmune drugs | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQN25Ld2RhUmVzSzV1M0ctdTl3TkZ2QV9HN3lEc0kycFlrcGU3cTBoQ1o1ekJXcDFaQUFJZFBFMlAwTkZGUjRTUlIxeWlKWDByRVRFbjlqVG9lOU1MbEtSV1VPeUtlNzVQNXF3eGZlaWZHRG5QbW0wam9lMWhIMENjOGlGMXMwcGk5XzFSM0NVdEhPRXhS?oc=5) |
| Endpoints News | AbbVie makes $10.9B move for Apogee’s long-acting I&I drug candidates | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQbm9TRTFUQkVHS0F6ZXpEYklaMGJMdmZnUFBDMzZSdmlTaGpIaW56SVVGOXZrem1ZYnk0TnlfcGVxY3BFREYyU2xqOGstQ0lORklUMVFQd1NTTjJPYWNISHMxdEN3Zjc3WFpVNHhOZ2RhYkF3ZVhKdGtSeHlWQ1EyU1pCa0RHR2w5dk1PZmZ1Y1FfNXRk?oc=5) |
| NBC Boston | AbbVie paying $10.9B to buy Waltham biotech | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxNRlpRVXBCX0Rqd2VTWS05YmRsYnlHVDBuNE9hRk1MNTlsZl9QSkNBTUVvSFRWNm00akoyTG1zRXhpUkhjWER2UjMzdUZMYkFSV0JHMmxSenlGTFNKc0MzMXAzdlFUVXJxOGFnaVdmdHdpTVpyZXNCMkxtZ19Dc1FmNUNQZXRVaTRmUWFTMUt4ZnVmNlNtV3hRNERNckdSSlRCSWU5eXNLVmloTExfQ3p30gG3AUFVX3lxTE0wczQ1bmhtSUdsREg5RzZDWnBLcWZYSkFPaGtVb1NkeUVhN0p1SEtrYnlhaHV5M3BLZFkyTzFjaXFuV2J5VW5uNHpTOUgtQVhkdExWZkdnblRYNlNvT3VndVNfWllFbldEU21qUUtENTRkWi14T2VvX2tLMkZpX1dFMTZOLWRwNzhCajZPY0I2blVWMEM1My1Kd2lXQ014NVZicEs) |
| Yahoo Finance | 3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxOS2lBS2lqa2NaTDFudkdZY1ZzWjJ4dFA0OUxxUS16NjNrQ09OTzBxa0xuRGUwM2RKbm83bmxZdnhPMVhOSnZxRFFlMkptTENKVmlaT3NsUjdfQUNXc0VPS0tjWVRiUmZHd25Rckl0TDNLdmNHUjB0aEJka293cjVqQXV5cVJwRGNnNXFrYnRzYTktUC1RaVlV?oc=5) |
| WSJ | AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion | 2026-06-22 15:48 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxPc1M0S3F5YkFqVV9kQkhuVDdxME5oNkhHZU1ON0dhT2NyeFRSejVlV1EzRFFRREljTlNfazdGV2gtOWtHXzNHbFA3T0F2a0JucnlxMFQzNU9DY0UxVVFnSUtvZnJvYTVrWkJFYnFKNkZtR01QcmZoaF83SGdHN05lVjRabFNYTFNrOEhvUEpEdlo4MURxZGszbGZYU2ZNODEyZUxwcg?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-23/abbvie-to-buy-immunology-drugmaker-apogee-for-10-9-billion*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*